The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Regulation of the c-Abl and Bcr–Abl tyrosine kinases
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PyMOL Molecular Graphics System
DeLano, W. L. (2002) · Medical Entomology and Zoology · Cited by 18,147
The protein kinase complement of the human genome
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145
Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., Lydon, N. B., Kantarjian, H., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,243
Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm
Wright, P. E., & Dyson, H. J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3110 · Cited by 2,968
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
Druker, B. J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. B. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 2,967
PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors
Heinrich, M. C., Corless, C. L., Duensing, A., McGreevey, L., Chen, C.-J., Joseph, N., Singer, S., Griffith, D. J., Haley, A., Town, A., et al. (2003) · Science · doi:10.1126/science.1079666 · Cited by 2,301
Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase
Schindler, T., Bornmann, W., Pellicena, P., Miller, W. T., Clarkson, B., & Kuriyan, J. (2000) · Science · doi:10.1126/science.289.5486.1938 · Cited by 1,780
Daley, G. Q., Van Etten, R. A., & Baltimore, D. (1990) · Science · doi:10.1126/science.2406902 · Cited by 1,756
The Conformational Plasticity of Protein Kinases
Huse, M., & Kuriyan, J. (2002) · Cell · doi:10.1016/s0092-8674(02)00741-9 · Cited by 1,752
Caspase structure, proteolytic substrates, and function during apoptotic cell death
Nicholson, D. (1999) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400598 · Cited by 1,543
Three-dimensional structure of the tyrosine kinase c-Src
Xu, W., Harrison, S. C., & Eck, M. J. (1997) · Nature · doi:10.1038/385595a0 · Cited by 1,418
Resh, M. D. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(99)00075-0 · Cited by 1,250
Tyrosine phosphorylation of the fission yeast cdc2+ protein kinase regulates entry into mitosis
Gould, K. L., & Nurse, P. (1989) · Nature · doi:10.1038/342039a0 · Cited by 1,218
Crystal structure of the Src family tyrosine kinase Hck
Sicheri, F., Moarefi, I., & Kuriyan, J. (1997) · Nature · doi:10.1038/385602a0 · Cited by 1,172
Heinrich, M. C., Griffith, D. J., Druker, B. J., Wait, C. L., Ott, K. A., & Zigler, A. J. (2000) · Blood · doi:10.1182/blood.v96.3.925 · Cited by 1,071
Buchdunger, E., Zimmermann, J., Mett, H., Meyer, T., Müller, M., Druker, B. J., & Lydon, N. (1996) · PubMed · Cited by 1,057
Chronic Myeloid Leukemia — Advances in Biology and New Approaches to Treatment
Goldman, J. M., & Melo, J. V. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020777 · Cited by 950
Nagar, B., Bornmann, W. G., Pellicena, P., Schindler, T. H., Veach, D. R., Miller, W. T., Clarkson, B. D., & Kuriyan, J. (2002) · PubMed · Cited by 923
Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy
Hochhaus, A., Kreil, S., Corbin, A., La Rosée, P., Müller, M., Lahaye, T., Hanfstein, B., Schoch, C., Cross, N., Berger, U., et al. (2002) · Leukemia · doi:10.1038/sj.leu.2402741 · Cited by 906
Structural Basis for the Autoinhibition of c-Abl Tyrosine Kinase
Nagar, B., Hantschel, O., Young, M. A., Scheffzek, K., Veach, D., Bornmann, W., Clarkson, B., Superti-Furga, G., & Kuriyan, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00194-6 · Cited by 879
Self-citationEssential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression
Neumann, C. A., Krause, D. S., Carman, C. V., Das, S., Dubey, D. P., Abraham, J. L., Bronson, R. T., Fujiwara, Y., Orkin, S. H., & Van Etten, R. A. (2003) · Nature · doi:10.1038/nature01819 · Cited by 801
SH3 domains: complexity in moderation
Mayer, B. J. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.7.1253 · Cited by 788
Myristylation and palmitylation of Src family members: The fats of the matter
Resh, M. D. (1994) · Cell · doi:10.1016/0092-8674(94)90104-x · Cited by 700
Pendergast, A. M., Quilliam, L. A., Cripe, L. D., Bassing, C. H., Dai, Z., Li, N., Batzer, A., Rabun, K. M., Der, C. J., Schlessinger, J., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90689-n · Cited by 659
Mechanisms of Autoinhibition and STI-571/Imatinib Resistance Revealed by Mutagenesis of BCR-ABL
Azam, M., Latek, R. R., & Daley, G. Q. (2003) · Cell · doi:10.1016/s0092-8674(03)00190-9 · Cited by 613
Phosphoinositide Recognition Domains
Lemmon, M. A. (2003) · Traffic · doi:10.1034/j.1600-0854.2004.00071.x · Cited by 563
The Biology and Enzymology of ProteinN-Myristoylation
Farazi, T. A., Waksman, G., & Gordon, J. I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100042200 · Cited by 555
Baskaran, R., Wood, L. D., Whitaker, L. L., Canman, C. E., Morgan, S. E., Xu, Y., Barlow, C., Baltimore, D., Wynshaw-Boris, A., Kastan, M. B., et al. (1997) · Nature · doi:10.1038/387516a0 · Cited by 539
Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15.
McGowan, C. H., & Russell, P. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05633.x · Cited by 493
Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation
Yamaguchi, H., & Hendrickson, W. A. (1996) · Nature · doi:10.1038/384484a0 · Cited by 492
A Myristoyl/Phosphotyrosine Switch Regulates c-Abl
Hantschel, O., Nagar, B., Guettler, S., Kretzschmar, J., Dorey, K., Kuriyan, J., & Superti-Furga, G. (2003) · Cell · doi:10.1016/s0092-8674(03)00191-0 · Cited by 480
Self-citationInteraction between ATM protein and c-Abl in response to DNA damage
Shafman, T., Khanna, K. K., Kedar, P., Spring, K., Kozlov, S., Yen, T., Hobson, K., Gatei, M., Zhang, N., Watters, D., et al. (1997) · Nature · doi:10.1038/387520a0 · Cited by 478
Plattner, R., Kadlec, L., DeMali, K. A., Kazlauskas, A., & Pendergast, A. M. (1999) · Genes & Development · doi:10.1101/gad.13.18.2400 · Cited by 427
McWhirter, J. R., Galasso, D. L., & Wang, J. Y. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7587 · Cited by 420
Van Etten, R. A., Jackson, P., & Baltimore, D. (1989) · Cell · doi:10.1016/0092-8674(89)90102-5 · Cited by 413
Lymphosarcoma: virus-induced thymic-independent disease in mice.
Abelson, H. T., & Rabstein, L. S. (1970) · PubMed · Cited by 409
SH2 domains, interaction modules and cellular wiring
Pawson, T., Gish, G. D., & Nash, P. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02154-7 · Cited by 408
Welch, P. (1993) · Cell · doi:10.1016/0092-8674(93)90497-e · Cited by 407
Zukerberg, L. R., Patrick, G. N., Nikolic, M., Humbert, S., Wu, C.-L., Lanier, L. M., Gertler, F. B., Vidal, M., Van Etten, R. A., & Tsai, L.-H. (2000) · Neuron · doi:10.1016/s0896-6273(00)81200-3 · Cited by 395
Young, M. A., Gonfloni, S., Superti-Furga, G., Roux, B., & Kuriyan, J. (2001) · Cell · doi:10.1016/s0092-8674(01)00301-4 · Cited by 386
Self-citationc-Abl kinase regulates the protein binding activity of c-Crk.
Feller, S. M., Knudsen, B., & Hanafusa, H. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06518.x · Cited by 363
Genomic analysis of the eukaryotic protein kinase superfamily: a perspective.
Hanks, S. K. (2003) · Genome biology · doi:10.1186/gb-2003-4-5-111 · Cited by 328
Cycling, stressed-out and nervous: cellular functions of c-Abl
Van Etten, R. A. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01549-4 · Cited by 321
Smith, C. I. E., Islam, T. C., Mattsson, P. T., Mohamed, A. J., Nore, B. F., & Vihinen, M. (2001) · BioEssays · doi:10.1002/bies.1062 · Cited by 313
Nuclear-cytoplasmic shuttling of C-ABL tyrosine kinase
Taagepera, S., McDonald, D., Loeb, J. E., Whitaker, L. L., McElroy, A. K., Wang, J. Y. J., & Hope, T. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7457 · Cited by 311
The Abl family kinases: Mechanisms of regulation and signaling
(2002) · Advances in Cancer Research · doi:10.1016/s0065-230x(02)85003-5 · Cited by 296
Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry
Salomon, A. R., Ficarro, S. B., Brill, L. M., Brinker, A., Phung, Q. T., Ericson, C., Sauer, K., Brock, A., Horn, D. M., Schultz, P. G., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2436191100 · Cited by 279
N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl.
Jackson, P., & Baltimore, D. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03397.x · Cited by 278
Brasher, B. B., & Van Etten, R. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005401200 · Cited by 278
Van Etten, R. A. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.124.3.325 · Cited by 268
Wen, S.-T., & Van Etten, R. A. (1997) · Genes & Development · doi:10.1101/gad.11.19.2456 · Cited by 265
Roumiantsev, S., Shah, N. P., Gorre, M. E., Nicoll, J., Brasher, B. B., Sawyers, C. L., & Van Etten, R. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162140299 · Cited by 253
Functional interaction between DNA-PK and c-Abl in response to DNA damage
Kharbanda, S., Pandey, P., Jin, S., Inoue, S., Bharti, A., Yuan, Z.-M., Weichselbaum, R., Weaver, D., & Kufe, D. (1997) · Nature · doi:10.1038/386732a0 · Cited by 251
Williams, J. C., Weijland, A., Gonfloni, S., Thompson, A., Courtneidge, S. A., Superti-Furga, G., & Wierenga, R. K. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1426 · Cited by 250
Self-citationPluk, H., Dorey, K., & Superti-Furga, G. (2002) · Cell · doi:10.1016/s0092-8674(02)00623-2 · Cited by 248
Self-citationRegulation of F-actin-dependent processes by the Abl family of tyrosine kinases
Woodring, P. J., Hunter, T., & Wang, J. Y. J. (2003) · Journal of Cell Science · doi:10.1242/jcs.00622 · Cited by 227
An intramolecular SH3-domain interaction regulates c-Abl activity
Barilá, D., & Superti-Furga, G. (1998) · Nature Genetics · doi:10.1038/ng0398-280 · Cited by 216
Self-citationFranz, W. M., Berger, P., & Wang, J. Y. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03358.x · Cited by 202
Structure‐function relationships in Src family and related protein tyrosine kinases
Superti‐Furga, G., & Courtneidge, S. A. (1995) · BioEssays · doi:10.1002/bies.950170408 · Cited by 200
Self-citationVariation on an Src-like Theme
Harrison, S. C. (2003) · Cell · doi:10.1016/s0092-8674(03)00196-x · Cited by 186
Woodring, P. J., Litwack, E. D., O'Leary, D. D. M., Lucero, G. R., Wang, J. Y. J., & Hunter, T. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200110014 · Cited by 165
Structure and function of the SH3 domain
Musacchio, A., Wilmanns, M., & Saraster, M. (1994) · Progress in Biophysics and Molecular Biology · doi:10.1016/0079-6107(94)90003-5 · Cited by 162
Autoinhibition of Bcr-Abl through Its SH3 Domain
Smith, K. M., Yacobi, R., & Van Etten, R. A. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00274-0 · Cited by 162
Structure of the Bcr-Abl oncoprotein oligomerization domain.
Zhao, X., Ghaffari, S., Lodish, H. F., Malashkevich, V. N., & Kim, P. S. (2002) · PubMed · doi:10.1038/nsb747 · Cited by 145
Two Distinct Phosphorylation Pathways Have Additive Effects on Abl Family Kinase Activation
Tanis, K. Q., Veach, D. R., Duewel, H. S., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.11.3884-3896.2003 · Cited by 143
Bcr–Abl variants: biological and clinical aspects
Advani, A. S., & Pendergast, A. M. (2002) · Leukemia Research · doi:10.1016/s0145-2126(01)00197-7 · Cited by 142
Structure of N-myristoyltransferase with bound myristoylCoA and peptide substrate analogs
Bhatnagar, R. S., Fütterer, K., Farazi, T. A., Korolev, S., Murray, C. L., Jackson-Machelski, E., Gokel, G. W., Gordon, J. I., & Waksman, G. (1998) · Nature Structural Biology · doi:10.1038/4202 · Cited by 136
p53 dependent growth suppression by the c-Abl nuclear tyrosine kinase.
Goga, A., Liu, X., Hambuch, T. M., Senechal, K., Major, E., Berk, A. J., Witte, O. N., & Sawyers, C. L. (1995) · PubMed · Cited by 133
Domain movements in protein kinases
Cox, S. E., Radzio-Andzelm, E., & Taylor, S. S. (1994) · Current Opinion in Structural Biology · doi:10.1016/0959-440x(94)90272-0 · Cited by 131
c‐Abl is an effector of Src for growth factor‐induced c‐myc expression and DNA synthesis
Furstoss, O., Dorey, K., Simon, V., Barilà, D., Superti‐Furga, G., & Roche, S. (2002) · The EMBO Journal · doi:10.1093/emboj/21.4.514 · Cited by 128
Self-citationStructure of a photoactive rhodium complex intercalated into DNA.
Barton, J. K., Rees, D. C., Kielkopf, C. L., Erkkila, K. E., & Hudson, B. P. (2000) · Nature Structural Biology · doi:10.1038/72385 · Cited by 127
Integrins Regulate the Association and Phosphorylation of Paxillin by c-Abl
Lewis, J. M., & Schwartz, M. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14225 · Cited by 127
Zhang, X., Subrahmanyam, R., Wong, R., Gross, A. W., & Ren, R. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.3.840-853.2001 · Cited by 125
A new link between the c-Abl tyrosine kinase and phosphoinositide signalling through PLC-γ1
Plattner, R., Irvin, B. J., Guo, S., Blackburn, K., Kazlauskas, A., Abraham, R. T., York, J. D., & Pendergast, A. M. (2003) · Nature Cell Biology · doi:10.1038/ncb949 · Cited by 125
Signal transduction by wild-type and leukemogenic Abl proteins
Raitano, A. B., Whang, Y. E., & Sawyers, C. L. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00023-1 · Cited by 102
Dorey, K., Engen, J. R., Kretzschmar, J., Wilm, M. S., Neubauer, G., Schindler, T. H., & Superti‐Furga, G. (2001) · Oncogene · doi:10.1038/sj.onc.1205017 · Cited by 94
Self-citationA nuclear tyrosine phosphorylation circuit: c‐Jun as an activator and substrate of c‐Abl and JNK
Barilà, D., Mangano, R., Gonfloni, S., Kretzschmar, J., Moro, M., Bohmann, D., & Superti‐Furga, G. (2000) · The EMBO Journal · doi:10.1093/emboj/19.2.273 · Cited by 87
Self-citationDruker, B. J., Sawyers, C. L., Capdeville, R., Ford, J., Baccarani, M., & Goldman, J. M. (2001) · Hematology · doi:10.1182/asheducation-2001.1.87 · Cited by 73
Rajasekaran, B., Chiang, G. G., & Wang, J. Y. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3361 · Cited by 67
Juang, J., & Hoffmann, F. M. (1999) · Oncogene · doi:10.1038/sj.onc.1202911 · Cited by 66
Druker, B. J., O’Brien, S. G., Cortes, J., & Radich, J. (2002) · Hematology · doi:10.1182/asheducation-2002.1.111 · Cited by 62
Phosphotyrosine Mapping in Bcr/Abl Oncoprotein Using Phosphotyrosine-specific Immonium Ion Scanning
Steen, H., Fernandez, M. M., Ghaffari, S., Pandey, A., & Mann, M. (2003) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m300001-mcp200 · Cited by 54
Nonmyristoylated Abl Proteins Transform a Factor-Dependent Hematopoietic Cell Line
Daley, G. Q., Etten, R. A. V., Jackson, P. K., Bernards, A., & Baltimore, D. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.4.1864 · Cited by 53
Oncogenic Activation of c -ABL by Mutation within Its Last Exon
Goga, A., McLaughlin, J., Pendergast, A. M., Parmar, K., Muller, A. J., Rosenberg, N. E., & Witte, O. N. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.8.4967 · Cited by 52
ABL mechanisms of regulation and activation
Mayer, B. J. (2002) · Frontiers in bioscience · doi:10.2741/a767 · Cited by 51
Functional interaction between c-Abl and the p21-activated protein kinase γ-PAK
Roig, J., Tuazon, P. T., Zipfel, P. A., Pendergast, A. M., & Traugh, J. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14346 · Cited by 48
Activation of c-Abl Kinase Activity and Transformation by a Chemical Inducer of Dimerization
Smith, K. M., & Etten, R. A. V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100786200 · Cited by 46
Smith, J. M., Katz, S., & Mayer, B. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.39.27956 · Cited by 46
c-Abl regulation: a tail of two lipids
Etten, R. A. V. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00528-1 · Cited by 38
An Activating Mutation in the ATP Binding Site of the ABL Kinase Domain
Allen, P. B., & Wiedemann, L. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19585 · Cited by 33
Reynolds, F. H., Oroszlan, S., & Stephenson, J. R. (1982) · Journal of Virology · doi:10.1128/jvi.44.3.1097-1101.1982 · Cited by 18
David‐Cordonnier, M., Payet‐Bornet, D., D'Halluin, J.-C., Waring, M. J., TRAVERS, A. A., & Bailly, C. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.11.2265 · Cited by 14
Cited by
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Bantscheff, M., Eberhard, D., Abraham, Y., Bastuck, S., Boesche, M., Hobson, S., Mathieson, T., Perrin, J., Raida, M., Rau, C., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1328 · Cited by 1,034
Patil, R., Das, S., Stanley, A., Yadav, L., Sudhakar, A., & Varma, A. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012029 · Cited by 763
Molecular biology of bcr-abl1–positive chronic myeloid leukemia
Quintás-Cardama, A., & Cortes, J. (2009) · Blood · doi:10.1182/blood-2008-03-144790 · Cited by 745
PROTACs: great opportunities for academia and industry
Sun, X., Gao, H., Yang, Y., He, M., Wu, Y., Song, Y., Tong, Y., & Rao, Y. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0101-6 · Cited by 613
Modular PROTAC design for the degradation of oncogenic BCR-ABL
Lai, A. C., Toure, M., Hellerschmied, D., Salami, J., Jaime‐Figueroa, S., Ko, E., Hines, J., & Crews, C. M. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201507634 · Cited by 618
Metadata
- Authors
- Hantschel, O., & Superti-Furga, G.
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2004-01
- Volume
- 5
- Issue
- 1
- Pages
- 33-44
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2150148922
- Cited by
- 487
- References
- 92
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.